big4bio-logo-boston-2019-250

The Boston biomedical cluster includes 1000+ companies and is supported by research at leading universities and academic research centers; Kendall Square alone is home to more than 120 life science companies.

The sector has been encouraged through the investment of private and public capital, including the $1B commitment of the 2008 Massachusetts Life Sciences Act. Keep up with every development: Subscribe FREE to Big4Bio:Boston.

Subscribe
Subscribe

EVENT CENTER

sf-events
Boston is #1 when it comes to the number – and the quality — of events held here. Check out our event listings:

SPOTLIGHT

iStock_000008190739Small

Big4Bio Q&A: Dror Bashan, CEO of Protalix BioTherapeutics

LaVoieHealthScience Client Spotlight with Dror Bashan, CEO of Protalix BioTherapeutics Can you provide a brief overview of Protalix BioTherapeutics and its focus? Protalix BioTherapeutics is a unique biopharmaceutical company dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx® plant cell-based expression. Protalix was the first company ever to gain FDA approval for […]

Read More

SPONSORS

iStock_000014574578Large
Check out our regional sponsors and partners – they are leaders in their fields, and we thank them for their support!

SOCIAL MEDIA

twitter-292994_640
We provide even more information by aggregating industry-related videos, podcasts, and more with our social channels: